166 related articles for article (PubMed ID: 37118684)
1. Measurement invariance of the PHQ-9 and GAD-7 across males and females seeking treatment for common mental health disorders.
Saunders R; Moinian D; Stott J; Delamain H; Naqvi SA; Singh S; Wheatley J; Pilling S; Buckman JEJ
BMC Psychiatry; 2023 Apr; 23(1):298. PubMed ID: 37118684
[TBL] [Abstract][Full Text] [Related]
2. Measurement invariance and differential item functioning of the PHQ-9 and GAD-7 between working age and older adults seeking treatment for common mental disorders.
Delamain H; Buckman JEJ; Stott J; John A; Singh S; Pilling S; Saunders R
J Affect Disord; 2024 Feb; 347():15-22. PubMed ID: 37989437
[TBL] [Abstract][Full Text] [Related]
3. Are comparisons of mental disorders between Chinese and German students possible? An examination of measurement invariance for the PHQ-15, PHQ-9 and GAD-7.
Zhou Y; Xu J; Rief W
BMC Psychiatry; 2020 Oct; 20(1):480. PubMed ID: 33004042
[TBL] [Abstract][Full Text] [Related]
4. Psychometric properties and measurement invariance of the 7-item General Anxiety Disorder scale (GAD-7) in an Italian coronary heart disease population.
Bolgeo T; Di Matteo R; Simonelli N; Dal Molin A; Lusignani M; Bassola B; Vellone E; Maconi A; Iovino P
J Affect Disord; 2023 Aug; 334():213-219. PubMed ID: 37149049
[TBL] [Abstract][Full Text] [Related]
5. Measurement invariance of assessments of depression (PHQ-9) and anxiety (GAD-7) across sex, strata and linguistic backgrounds in a European-wide sample of patients after Traumatic Brain Injury.
Teymoori A; Real R; Gorbunova A; Haghish EF; Andelic N; Wilson L; Asendorf T; Menon D; von Steinbüchel N
J Affect Disord; 2020 Feb; 262():278-285. PubMed ID: 31732280
[TBL] [Abstract][Full Text] [Related]
6. Factor structure, measurement invariance, and concurrent validity of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder scale-7 in a Norwegian psychiatric outpatient sample.
Brattmyr M; Lindberg MS; Solem S; Hjemdal O; Havnen A
BMC Psychiatry; 2022 Jul; 22(1):461. PubMed ID: 35818021
[TBL] [Abstract][Full Text] [Related]
7. Measurement invariance of the Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) across four European countries during the COVID-19 pandemic.
Shevlin M; Butter S; McBride O; Murphy J; Gibson-Miller J; Hartman TK; Levita L; Mason L; Martinez AP; McKay R; Stocks TV; Bennett KM; Hyland P; Vallieres F; Valiente C; Vazquez C; Contreras A; Peinado V; Trucharte A; Bertamini M; Panzeri A; Bruno G; Granziol U; Mignemi G; Spoto A; Vidotto G; Bentall RP
BMC Psychiatry; 2022 Mar; 22(1):154. PubMed ID: 35232409
[TBL] [Abstract][Full Text] [Related]
8. Reliability and validity of the Patient Health Questionnaire-4 scale and its subscales of depression and anxiety among US adults based on nativity.
Adzrago D; Walker TJ; Williams F
BMC Psychiatry; 2024 Mar; 24(1):213. PubMed ID: 38500115
[TBL] [Abstract][Full Text] [Related]
9. On Dimensionality, Measurement Invariance, and Suitability of Sum Scores for the PHQ-9 and the GAD-7.
Stochl J; Fried EI; Fritz J; Croudace TJ; Russo DA; Knight C; Jones PB; Perez J
Assessment; 2022 Apr; 29(3):355-366. PubMed ID: 33269612
[TBL] [Abstract][Full Text] [Related]
10. Sexuality and gender invariance of the PHQ-9 and GAD-7: Implications for 16 identity groups.
Borgogna NC; Brenner RE; McDermott RC
J Affect Disord; 2021 Jan; 278():122-130. PubMed ID: 32956961
[TBL] [Abstract][Full Text] [Related]
11. Factorial invariance of the Patient Health Questionnaire and Generalized Anxiety Disorder Questionnaire.
Ryan TA; Bailey A; Fearon P; King J
Br J Clin Psychol; 2013 Nov; 52(4):438-49. PubMed ID: 24117915
[TBL] [Abstract][Full Text] [Related]
12. The Four-Dimensional Symptom Questionnaire (4DSQ) in the general population: scale structure, reliability, measurement invariance and normative data: a cross-sectional survey.
Terluin B; Smits N; Brouwers EP; de Vet HC
Health Qual Life Outcomes; 2016 Sep; 14(1):130. PubMed ID: 27629535
[TBL] [Abstract][Full Text] [Related]
13. Psychometric evaluation of the Generalized Anxiety Disorder Screener GAD-7, based on a large German general population sample.
Hinz A; Klein AM; Brähler E; Glaesmer H; Luck T; Riedel-Heller SG; Wirkner K; Hilbert A
J Affect Disord; 2017 Mar; 210():338-344. PubMed ID: 28088111
[TBL] [Abstract][Full Text] [Related]
14. Screening for psychological distress using the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS): Initial validation of structural validity in dialysis patients.
Chilcot J; Hudson JL; Moss-Morris R; Carroll A; Game D; Simpson A; Hotopf M
Gen Hosp Psychiatry; 2018; 50():15-19. PubMed ID: 28985589
[TBL] [Abstract][Full Text] [Related]
15. A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population.
Löwe B; Wahl I; Rose M; Spitzer C; Glaesmer H; Wingenfeld K; Schneider A; Brähler E
J Affect Disord; 2010 Apr; 122(1-2):86-95. PubMed ID: 19616305
[TBL] [Abstract][Full Text] [Related]
16. Psychometric properties of the Patient Health Questionnaire-4 (PHQ-4) in 9230 adults across seven European countries: Findings from the ESTSS ADJUST study.
Kazlauskas E; Gelezelyte O; Kvedaraite M; Ajdukovic D; Johannesson KB; Böttche M; Bondjers K; Dragan M; Figueiredo-Braga M; Grajewski P; Anastassiou-Hadjicharalambous X; Javakhishvili JD; Lioupi C; Lueger-Schuster B; Mouthaan J; Bagaric IR; Sales L; Schäfer I; Soydas S; Tsiskarishvili L; Zrnic Novakovic I; Lotzin A
J Affect Disord; 2023 Aug; 335():18-23. PubMed ID: 37164064
[TBL] [Abstract][Full Text] [Related]
17. Examining the psychometric properties of brief screening measures of depression and anxiety in chronic pain: The Patient Health Questionnaire 2-item and Generalized Anxiety Disorder 2-item.
Bisby MA; Karin E; Scott AJ; Dudeney J; Fisher A; Gandy M; Hathway T; Heriseanu AI; Staples L; Titov N; Dear BF
Pain Pract; 2022 Apr; 22(4):478-486. PubMed ID: 35258171
[TBL] [Abstract][Full Text] [Related]
18. Measurement Invariance of the GAD-7 and CESD-R-10 Among Adolescents in Canada.
Romano I; Ferro MA; Patte KA; Leatherdale ST
J Pediatr Psychol; 2022 May; 47(5):585-594. PubMed ID: 35552429
[TBL] [Abstract][Full Text] [Related]
19. Validation of brief screening measures for depression and anxiety in young people with substance use disorders.
Bentley KH; Sakurai H; Lowman KL; Rines-Toth L; McKowen J; Pedrelli P; Evins AE; Yule AM
J Affect Disord; 2021 Mar; 282():1021-1029. PubMed ID: 33601674
[TBL] [Abstract][Full Text] [Related]
20. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6.
Staples LG; Dear BF; Gandy M; Fogliati V; Fogliati R; Karin E; Nielssen O; Titov N
Gen Hosp Psychiatry; 2019; 56():13-18. PubMed ID: 30508772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
